Research

Biocitech technology park posts record number of partnerships in 2009

Biocitech SAS, the Paris life science technology park, announced that its 23 resident companies exceeded past performance again in 2009 with a significant increase in the number of agreements concluded with pharmaceutical and biopharmaceutical companies outside Biocitech. Biocitech has drawn attention in the past to the excellent working relationships forged between residents, and 2009 shows how successfully the residents are working internationally and with other companies in France.

Novoseek in the Virtual Library of the Spanish Council for Scientific Research

Novoseek, the free biomedical search engine developed by the bioinformatics company Bioalma, has been incorporated to electronic information resources available at the Spanish Council of Scientific Research (CSIC). This integration will permit members of the CSIC to access novoseek directly from the CSIC Virtual Library. All the novoseek users belonging to the CSIC, will find a direct link of to complete documents available at the CSIC Virtual Library.

Theranostics Paves the Way for Personalised Medicine in Europe

Theranostics is an emerging field in clinical diagnostics, focussing on developing specific analysis to predict the most suitable drug for a patient along with assessing the efficacy of the drug. It uses molecular assays to determine the optimum dose of drugs for a patient, paving the way for personalised medicine. Although significant awareness has been created about personalised medicine, its full potential is yet to be tapped.

New study highlights immune system's role in Alzheimer's

The brain's immune cells may be behind the loss of neurons associated with Alzheimer's disease, new EU-funded research suggests. The findings, published in the journal Nature Neuroscience, could lead to the development of new treatments for the neurodegenerative disease.

Aureus Pharma Announces its Participation in EUR 118 Million Biointelligence R&D Programme

Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today its participation in a EUR 118.2 million (USD 160 million) project. The project is the Biointelligence R&D programme, designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.

Prescribing Research Takes Priority at First DataBank Europe

First DataBank Europe announced sponsorship of the Prescribing and Prescriptions Management seminar to be held at independent research charity The King's Fund's premises in London on 23 March as part of the Inquiry into the Quality of General Practice.

Teijin Pharma Strengthens Presence in Spain's Home Healthcare Field

Teijin Pharma Limited, the core company of the Teijin Group’s pharmaceuticals and home healthcare business, announced today that it will significantly strengthen its presence in the Spanish home healthcare field as part of further expansion in the European market. Under the plan, OXIMEPLUS S.A., a Teijin group company and home healthcare equipment provider based in Andalusia, Spain, has been renamed Esteve Teijin Espana, S.A. (ETE) to better leverage the Teijin and Esteve brands.

Research & Development

Biocitech technology park posts record number of partnerships in 2009

Novoseek in the Virtual Library of the Spanish Council for Scientific Research

Theranostics Paves the Way for Personalised Medicine in Europe

New study highlights immune system's role in Alzheimer's

Aureus Pharma Announces its Participation in EUR 118 Million Biointelligence R&D Programme

Prescribing Research Takes Priority at First DataBank Europe

Teijin Pharma Strengthens Presence in Spain's Home Healthcare Field

More Pharma News ...